1. Home
  2. CDNS vs GSK Comparison

CDNS vs GSK Comparison

Compare CDNS & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNS
  • GSK
  • Stock Information
  • Founded
  • CDNS 1988
  • GSK 1715
  • Country
  • CDNS United States
  • GSK United Kingdom
  • Employees
  • CDNS N/A
  • GSK N/A
  • Industry
  • CDNS Computer Software: Prepackaged Software
  • GSK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CDNS Technology
  • GSK Health Care
  • Exchange
  • CDNS Nasdaq
  • GSK Nasdaq
  • Market Cap
  • CDNS 64.1B
  • GSK 71.7B
  • IPO Year
  • CDNS 1987
  • GSK N/A
  • Fundamental
  • Price
  • CDNS $305.78
  • GSK $36.64
  • Analyst Decision
  • CDNS Buy
  • GSK Hold
  • Analyst Count
  • CDNS 13
  • GSK 4
  • Target Price
  • CDNS $322.92
  • GSK $47.00
  • AVG Volume (30 Days)
  • CDNS 2.0M
  • GSK 5.4M
  • Earning Date
  • CDNS 04-28-2025
  • GSK 04-30-2025
  • Dividend Yield
  • CDNS N/A
  • GSK 4.36%
  • EPS Growth
  • CDNS 2.60
  • GSK N/A
  • EPS
  • CDNS 3.94
  • GSK 0.98
  • Revenue
  • CDNS $4,874,527,000.00
  • GSK $40,735,668,430.00
  • Revenue This Year
  • CDNS $14.06
  • GSK $7.19
  • Revenue Next Year
  • CDNS $11.96
  • GSK $5.34
  • P/E Ratio
  • CDNS $77.62
  • GSK $18.28
  • Revenue Growth
  • CDNS 19.55
  • GSK 2.57
  • 52 Week Low
  • CDNS $221.56
  • GSK $31.72
  • 52 Week High
  • CDNS $328.99
  • GSK $45.93
  • Technical
  • Relative Strength Index (RSI)
  • CDNS 65.65
  • GSK 44.68
  • Support Level
  • CDNS $302.29
  • GSK $36.42
  • Resistance Level
  • CDNS $313.00
  • GSK $39.23
  • Average True Range (ATR)
  • CDNS 7.87
  • GSK 0.76
  • MACD
  • CDNS 2.22
  • GSK -0.07
  • Stochastic Oscillator
  • CDNS 88.17
  • GSK 13.02

About CDNS Cadence Design Systems Inc.

Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house semiconductor design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Share on Social Networks: